Gilead settles patent disputes over Biktarvy with generic drugmakers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Gilead settles patent disputes over Biktarvy with generic drugmakers
Gilead Sciences (NASDAQ: GILD) Delayed: 149.61 -0.31 (0.21%)
Previous Close $149.92    52 Week High $108.63 
Open $150.00    52 Week Low $71.39 
Day High $152.55    P/E 82.66 
Day Low $148.83    EPS $1.81 
Volume 4,923,197